Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach

QR Code

Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tomas G Neilan, Judith Mueller, Samuel Peter Heilbroner, Reed Few, Jitesh Chalwa, Francois Charest, Somasekhar Suryadevara, Christine Kratt, Andres Gomez-Caminero, Brian Dreyfus
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/df40c0f34d4746c3a6cd70940f120f07
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Correction: Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
Publié: (2021)

SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
par: Paolo Antonio Ascierto, et autres
Publié: (2021)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
par: Zheng-Hang Wang, et autres
Publié: (2018)

Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
Publié: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
par: Zoe Apalla, et autres
Publié: (2021)

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
par: Ying Jing, et autres
Publié: (2020)

Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review
par: Marina A. Lyadova, et autres
Publié: (2021)

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
par: Rilan Bai, et autres
Publié: (2021)

The Mediating Processes between Depression and Cardiac Adverse Events
par: R Bagherian,, et autres
Publié: (2011)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
par: Xiaoyin Bai, et autres
Publié: (2021)

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
par: Kennedy Yao Yi Ng, et autres
Publié: (2021)

Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
par: Harvey RD
Publié: (2014)

Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors
par: Despina Michailidou, et autres
Publié: (2021)

Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
par: Imperiali Claudia E., et autres
Publié: (2020)

Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
par: Xiujing He, et autres
Publié: (2021)

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.
par: Karen Shean, et autres
Publié: (2013)

Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development
par: Ke Cheng, et autres
Publié: (2021)

Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR
par: Theresa L Walunas, et autres
Publié: (2021)

Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis
par: Nuttapong Ngamphaiboon, et autres
Publié: (2021)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
par: Han N, et autres
Publié: (2021)

Risk factors of postoperative major adverse cardiac events after radical cystectomy: implication of diastolic dysfunction
par: In-Jung Jun, et autres
Publié: (2019)

Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab
par: Rosaria De Filippi, et autres
Publié: (2021)

Do endocrine adverse events predict longer progression-free survival among patients with non-small-cell lung cancer receiving nivolumab?
par: Izabela Chmielewska, et autres
Publié: (2021)

Relative risks of adverse events among older adults receiving opioids versus NSAIDs after hospital discharge: A nationwide cohort study.
par: Shoshana J Herzig, et autres
Publié: (2021)

Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
par: Woorim Kim, et autres
Publié: (2021)

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
par: Petros Isaakidis, et autres
Publié: (2012)

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
par: Di Wang, et autres
Publié: (2021)

Atrial high-rate episodes predict major adverse cardio/cerebrovascular events in patients with cardiac implantable electrical devices
par: Ju-Yi Chen, et autres
Publié: (2021)

Traditional cardiovascular risk factors are associated with adverse cardiac events in pregnant women with elevated right ventricular systolic pressure
par: William Marshall, et autres
Publié: (2021)

Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
par: Can Öztürk, et autres
Publié: (2021)

Travelers’ vaccines and their adverse events in Nara, Japan
par: Ogawa Taku, et autres
Publié: (2021)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
par: Hayato Katsuno, et autres
Publié: (2021)

Cardiac expression of microRNA-7 is associated with adverse cardiac remodeling
par: Manveen K. Gupta, et autres
Publié: (2021)

Pulmonary Artery Stiffness by Cardiac Magnetic Resonance Imaging Predicts Major Adverse Cardiovascular Events in patients with Chronic Obstructive Pulmonary Disease
par: Lucia Agoston-Coldea, et autres
Publié: (2018)

Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA
par: Kun-Hsing Yu, et autres
Publié: (2021)

Urocortin Role in Ischemia Cardioprotection and the Adverse Cardiac Remodeling
par: Eva M. Calderón-Sánchez, et autres
Publié: (2021)

Incidentally identified coronary artery calcium on non-contrast CT scan of the chest predicts major adverse cardiac events among hospital inpatients
par: Austin C C Ng, et autres
Publié: (2021)

Systemic adverse events after screening of retinopathy of prematurity with mydriatic.
par: Shumpei Obata, et autres
Publié: (2021)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
par: Hanley T, et autres
Publié: (2016)

NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
par: Zuoan Qin, et autres
Publié: (2021)